Cargando…

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant

The recent emergence of the Omicron variant has raised concerns on vaccine efficacy and the urgent need to study more efficient vaccination strategies. Here we observed that an mRNA vaccine booster in individuals vaccinated with two doses of inactivated vaccine significantly increased the plasma lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Fanglei, Abolhassani, Hassan, Du, Likun, Piralla, Antonio, Bertoglio, Federico, de Campos-Mata, Leire, Wan, Hui, Schubert, Maren, Cassaniti, Irene, Wang, Yating, Sammartino, Josè Camilla, Sun, Rui, Vlachiotis, Stelios, Bergami, Federica, Kumagai-Braesch, Makiko, Andréll, Juni, Zhang, Zhaoxia, Xue, Yintong, Wenzel, Esther Veronika, Calzolai, Luigi, Varani, Luca, Rezaei, Nima, Chavoshzadeh, Zahra, Baldanti, Fausto, Hust, Michael, Hammarström, Lennart, Marcotte, Harold, Pan-Hammarström, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106736/ https://www.ncbi.nlm.nih.gov/pubmed/35562366 http://dx.doi.org/10.1038/s41467-022-30340-5

Ejemplares similares

Immunity to SARS-CoV-2 up to 15 months after infection
por: Marcotte, Harold, et al.
Publicado: (2022)

Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
por: Zuo, Fanglei, et al.
Publicado: (2023)

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection
por: Sherina, Natalia, et al.
Publicado: (2021)

Design, structure and plasma binding of ancestral β-CoV scaffold antigens
por: Hueting, David, et al.
Publicado: (2023)

Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients—a perspective
por: Hammarström, Lennart, et al.
Publicado: (2020)

SARS-CoV-2–specific B- and T-cell immunity in a population-based study of young Swedish adults
por: Björkander, Sophia, et al.
Publicado: (2022)

Antibody therapy for COVID-19
por: Hammarström, Lennart, et al.
Publicado: (2021)

Hallmarks of Cancers: Primary Antibody Deficiency Versus Other Inborn Errors of Immunity
por: Abolhassani, Hassan, et al.
Publicado: (2021)

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
por: Schubert, Maren, et al.
Publicado: (2022)

SARS-CoV-2 infection in patients with inborn errors of immunity due to DNA repair defects: DNA repair deficiency and COVID19
por: Wang, Yating, et al.
Publicado: (2022)

Passive Immunization: Toward Magic Bullets
por: Marcotte, Harold, et al.
Publicado: (2015)

Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19
por: Abolhassani, Hassan, et al.
Publicado: (2022)

X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia
por: Abolhassani, Hassan, et al.
Publicado: (2021)

Impact of Viral Decontamination Method on Cytokine Profile of COVID-19 Patients
por: Magrì, Davide, et al.
Publicado: (2021)

Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study
por: Cassaniti, Irene, et al.
Publicado: (2022)

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
por: Marcotte, Harold, et al.
Publicado: (2022)

SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay
por: Cassaniti, Irene, et al.
Publicado: (2021)

19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern
por: García-Vega, Melissa, et al.
Publicado: (2023)

Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital
por: Sammartino, Josè Camilla, et al.
Publicado: (2022)

Genomic characterization of lymphomas in patients with inborn errors of immunity
por: Ye, Xiaofei, et al.
Publicado: (2022)

SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
por: Kim, Eun, et al.
Publicado: (2023)

Adapting Neutralizing Antibodies to Viral Variants by Structure‐Guided Affinity Maturation Using Phage Display Technology
por: Peissert, Frederik, et al.
Publicado: (2023)

Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers
por: Bergami, Federica, et al.
Publicado: (2022)

Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
por: Yuki, Yoshikazu, et al.
Publicado: (2022)

SARS-CoV-2 positivity in rectal swabs: implication for possible transmission
por: Novazzi, Federica, et al.
Publicado: (2020)

Macrophages and Monocytes: “Trojan Horses” in COVID-19
por: Percivalle, Elena, et al.
Publicado: (2021)

Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome
por: Abolhassani, Hassan, et al.
Publicado: (2022)

Updates of cancer hallmarks in patients with inborn errors of immunity
por: Wang, Yating, et al.
Publicado: (2022)

Molecular Epidemiology of Rhinovirus/Enterovirus and Their Role on Cause Severe and Prolonged Infection in Hospitalized Patients
por: Giardina, Federica A. M., et al.
Publicado: (2022)

Lung function before and after COVID-19 in young adults: A population-based study
por: Mogensen, Ida, et al.
Publicado: (2022)

Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant
por: Cassaniti, Irene, et al.
Publicado: (2021)

Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern
por: Lasagna, A., et al.
Publicado: (2022)

Histocompatibility Complex Status and Mendelian Randomization Analysis in Unsolved Antibody Deficiency
por: Abolhassani, Hassan, et al.
Publicado: (2020)

Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up
por: Lasagna, Angioletta, et al.
Publicado: (2023)

Persistent rhinovirus infection in pediatric hematopoietic stem cell transplant recipients with impaired cellular immunity
por: Piralla, Antonio, et al.
Publicado: (2015)

Overexpression of membrane proteins in mammalian cells for structural studies
por: Andréll, Juni, et al.
Publicado: (2013)

Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations
por: King, Jovanka R., et al.
Publicado: (2023)

SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers
por: Rovida, Francesca, et al.
Publicado: (2021)

Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
por: Lasagna, A., et al.
Publicado: (2021)

Lactobacillus delivery of bioactive interleukin-22
por: Lin, Yin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_116ti086odm819841toiji5i02